Udo Eichenlaub

Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia

Shorena Janelidze, Niklas Mattsson, Sebastian Palmqvist et al. · Nature Medicine · 2020 · 1.3K citations

Life Sciences, Neurology, Neuroscience +17

CSF biomarkers of Alzheimer's disease concord with amyloid‐β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts

Oskar Hansson, John Seibyl, Erik Stomrud et al. · Alzheimer s & Dementia · 2018 · 829 citations · Full text

Medicine, Neurology, Neuroscience +17

Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease

Shorena Janelidze, Charlotte E. Teunissen, Henrik Zetterberg et al. · JAMA Neurology · 2021 · 502 citations · Full text

Medicine, Neurology, Neuroscience +17

Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid Status

Sebastian Palmqvist, Shorena Janelidze, Erik Stomrud et al. · JAMA Neurology · 2019 · 449 citations · Full text

Medicine, Neurology, Neuroscience +17

Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β‐amyloid (1–42) in human cerebrospinal fluid

Tobias Bittner, Henrik Zetterberg, Charlotte E. Teunissen et al. · Alzheimer s & Dementia · 2015 · 392 citations · Full text

Medicine, Neurology, Biosensors +16